Inactivated bacterial vaccine

This page covers all Inactivated bacterial vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Salmonella typhi Vi polysaccharide antigen, Bacillus anthracis protective antigen (PA) and lethal factor.

Targets

Salmonella typhi Vi polysaccharide antigen · Bacillus anthracis protective antigen (PA) and lethal factor

Marketed (3)

• Typhim Vi (Sanofi Pasteur MSD) · Universitaire Ziekenhuizen KU Leuven · Immunology / Infectious Disease
  Typhim Vi is an inactivated typhoid vaccine that stimulates the immune system to produce antibodies against Salmonella typhi polysaccharide antigen.
• AVA · Emergent BioSolutions · Immunology / Infectious Disease
  AVA is an anthrax vaccine that stimulates the immune system to produce antibodies against anthrax toxins, providing protection against infection by Bacillus anthracis.
• Boostrix™-US formulation · GlaxoSmithKline · Immunology / Infectious Disease
  Boostrix is a vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, and pertussis (whooping cough) pathogens.